About Myezom
Myezom is a first-string, superior antineoplastic agent, expertly formulated with Bortezomib 2 mg per vial. This gilt-edged medicine is presented as a single-use, ephemeral lyophilized powder for injection, tailored for intravenous or subcutaneous administration. Its personalised approach ensures optimal efficiency in the treatment of multiple myeloma and mantle cell lymphoma. Scarce in supply and reserved exclusively for hospital use under qualified physician supervision, Myezom represents a high-grade, market-registered product designed for adults. Strictly prescription-based, its efficacy stands unparalleled among proteasome inhibitors.
Myezoms Competitive Edge & Unique Features
Myezoms primary advantage lies in its scarce availability and superior efficacy as a proteasome inhibitor. Marketed as a gilt-edged, sterile lyophilized powder, this antineoplastic agent ensures first-string therapeutic results. Its single-use vial guarantees personalisation in dosing, aligning with hospital protocols for safety and accuracy. Enhanced by allopathic origin and ideal for multiple myeloma and mantle cell lymphoma, Myezom is strictly handled by experts, assuring superior results for patients in need of advanced cancer care.
Myezoms Premium Payment Terms & Sample Availability
Shipped across Indias main domestic markets at the lowest price, Myezom comes with premium customer service for dealers, distributors, exporters, suppliers, traders, and wholesalers. Samples are available upon request to ensure customer confidence before bulk purchase. Payment terms are flexible, supporting streamlined procurement for healthcare providers. Its packagingone vial per boxhighlights the emphasis on quality and reliability, making Myezom a preferred choice for medical facilities seeking assured antineoplastic solutions.
FAQs of Myezom:
Q: How is Myezom administered for therapeutic use?
A: Myezom is administered either intravenously or subcutaneously after reconstitution with sterile water for injection. Hospital use under a supervised, qualified physician is mandatory to ensure safe and effective dosing.
Q: What conditions is Myezom recommended to treat?
A: Myezom is principally indicated for adults diagnosed with multiple myeloma and mantle cell lymphoma, functioning as a potent anti-cancer and proteasome inhibitor treatment option.
Q: When should I check the expiry date for Myezom?
A: It is crucial to always check the expiry date on the product packaging before use, as the efficacy and safety of Myezom depend on its valid shelf-life.
Q: Where should Myezom be stored for optimal preservation?
A: Myezom should be stored below 25C, protected from light, in accordance with hospital storage guidelines to maintain its potency and effectiveness.
Q: What is the process for reconstituting Myezom prior to administration?
A: Reconstitution should be performed only with sterile water for injection, following the detailed instructions provided by the manufacturer and under the oversight of a qualified healthcare professional.
Q: Who is eligible for Myezom treatment?
A: Myezom is suitable for adults and is restricted to use under medical supervision, with caution advised during pregnancy or lactation unless recommended by a physician.